On the recordNovember 16, 2015
And so is it fair to conclude that your assessment is that the transparency related to your relationship with the pharmaceutical company, that it could produce higher costs for the consumer?
Source
congress.govEditor's note · Context
Cicilline questions the impact of transparency on pharmaceutical costs.
Share & report
More from David Cicilline
Apr 25, 2023
Again, I reiterate the fact that the children under Trump were snatched away from their families, purposely, to discourage them from coming.
Apr 18, 2023
Thank you for your testimony and most importantly for the important work that you are doing.
Other voices in this conversation
